Atara Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Atara Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Atara Biotherapeutics Inc
Rating: 1.63566675
Author: Trendlyne DVM scores

about

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and man...

9.30 0.07 (0.76%)

50.27% Fall from 52W High

30,021

XNAS Volume

XNAS 14 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.2 / 100

Technically Neutral

49.3 / 100

1Yr Price target upside is 72%

3 analysts

Atara Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Atara Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and man...

50.27% Fall from 52W High

SWOT Analysis

Atara Biotherapeutics Inc Live Price Chart